Otros idiomas Genetics Generation Advancement Corp.

Acciones

4160

TW0004160007

Precio de cierre Taipei Exchange Otros sitios de cotización 00:00:00 15/05/2024			Varia. Cinco días.	Varia. 1 de enero.
55,5 ^TWD	+3,54 %		-5,13 %	+42,67 %

25/03	Genetics Generation Advancement Corp. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023	CI
2023	Genetics Generation Advancement Corp. informa de los resultados del tercer trimestre y los nueve meses finalizados el 30 de septiembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Genetics Generation Advancement Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	25/03
Genetics Generation Advancement Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Genetics Generation Advancement Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	08/08/23
Genetics Generation Advancement Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
Genetics Generation Advancement Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23
Genetics Generation Advancement Corp. Proposes Cash Dividend for the Year Ended 31 December 2022	15/03/23
Genetics Generation Advancement Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/11/22
Genetics Generation Advancement : Announcement of the record date of cash dividend	15/08/22
Genetics Generation Advancement Corp. Announces Cash Dividend, Payable on September 30, 2022	15/08/22
Genetics Generation Advancement Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/08/22
Genetics Generation Advancement : Announcement of the Partial Correction of the Company's 2021 Annual Report	05/08/22
Genetics Generation Advancement : To announce that 2022Q2 Consolidated Financial Statement approved by the Board of Directors	03/08/22
Genetics Generation Advancement Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	12/05/22
Genetics Generation Advancement Corp. Approves Appointment of John Chang as Chief Technical Officer	03/05/22
Genetics Generation Advancement Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	30/03/22
Genetics Generation Advancement : Announce the release of non-competition restriction on managerial officer by the Board of Directors	17/03/22
Genetics Generation Advancement : Announce the change of the company’s Spokesperson,Financial Officer,Accounting Officer and Corporate Governance Officer	17/03/22
Genetics Generation Advancement : To announce that 2021 Consolidated Financial Statement approved by the Board of Directors	17/03/22
Genetics Generation Advancement : The Board of Directors resolved today the private placement proposals to be submitted to the coming shareholders meeting for decision	17/03/22
Genetics Generation Advancement : The Board of Directors resolved to convene the 2022 Annual Shareholders' Meeting	17/03/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Genetics Generation Advancement Corp.

Acciones

4160

TW0004160007

Otros idiomas

Filtros